Alzheimer’s Association International Conference 2023 (AAIC 2023)

Infrequent bowel movement tied to cognitive decline

Audrey Abella, 20230828100000

A study presented at AAIC 2023 has shown a link between less frequent bowel movement (ie, one every 3+ days) and cognitive function in adults.

High social engagement in midlife tied to lower dementia risk

Elaine Soliven, 20230823000000

Higher levels of social engagement during midlife are associated with a reduced risk of dementia later in life, according to a study presented at AAIC 2023.

Pimavanserin well tolerated in older patients with neurodegenerative disease

Elaine Soliven, 20230819000000

Pimavanserin therapy was well tolerated in frail adult and older patients with neuropsychiatric symptoms related to neurodegenerative disease (NDD) in a recent study presented at AAIC 2023.

Hearing-impaired adults may ACHIEVE cognitive benefit from hearing aids

Audrey Abella, 20230818100000

Findings from the ACHIEVE* study suggest that older adults who are at increased risk for cognitive decline and dementia and who have hearing loss may benefit the most from hearing intervention within 3 years.

Another win for donanemab in TRAILBLAZER Alzheimer’s trial

Audrey Abella, 20230814100000

In the phase III TRAILBLAZER-ALZ 2 study, donanemab significantly slowed clinical progression in individuals with early symptomatic Alzheimer’s disease* (AD) with amyloid and tau pathologies, demonstrating an important replication of the phase II findings.